Editorial Leadership

Tweet

John M. Fitzpatrick
George W. Drach
Karl-Erik Andersson
Mitchell C. Benson
Ralph V. Clayman
Roger R. Dmochowski
Pamela I. Ellsworth
Christopher P. Evans
Philip M. Hanno
William Jaffe
S. Bruce Malkowicz
Elspeth M. McDougall
Michael J. Metro
Harris M. Nagler
Ricardo Sanchez-Ortiz
David P. Wood, Jr.

 Co-Editor-in-Chief:

John M. Fitzpatrick
Professor and Chairman of the Department of Surgery, Mater Misericordiae Hospital and University College, Dublin, Ireland

John M. Fitzpatrick, MD MCh, FRCSI, FC Urol (SA), FRCSGlas, FRCS was born and educated in Dublin. He qualified as a doctor in 1971 and became fellow of the Royal College of Surgeons in Ireland in 1975. He received his master's degree in 1976. He is also a fellow of the Royal College of Surgeons of England and of Glasgow. Between 1977 and 1981, Professor Fitzpatrick trained in the St. Peters Hospitals and the Institute of Urology in London. In 1981, Professor Fitzpatrick returned to Dublin as Consultant Urologist and Senior Lecturer in Urology in the Meath and St. James' Hospitals and Trinity College Dublin. In 1986, he was appointed Professor and Chairman of the Department of Surgery in the Mater Misericordiae Hospital and University College Dublin.

Professor Fitzpatrick has performed 45 visiting professorships in the United States and other countries throughout the world. He has also given 167 guest lectures throughout the world. He has produced 260 peer-reviewed publications, 74 book chapters, has edited 6 journal editions, and published 12 books. Professor Fitzpatrick is on the editorial board of 25 journals, and is Editor-in-Chief of the British Journal of Urology International. He is President of the Irish Society Urology and is Past President of the British Association of Urological Surgeons. He is a member of the Board of Trustees of the British Urological Foundation and is Chairman of the Scientific Committee of that Foundation. He is an Honorary Fellow of the College of Urologists of South Africa and an honorary member of the British Association of Urological Surgeons and of the American Urological Association as well as an honorary member of the Urological Societies of Australasia, South Africa, Germany, Netherlands, Hungary, Argentina, Greece, and Georgia.

Medical Editor Emeritus:

George W. Drach
Professor of Urology and Director of Outpatient Urology Education, University of Pennsylvania, Philadelphia, PA USA

George W. Drach, MD, FACS has served as Professor of Urology and Director of Outpatient Urology Education at the University of Pennsylvania since 1998. From 1996 to 1998, he visited the University of Texas Southwestern Medical School in Dallas as Professor of Urology and directed the Urology Clinic at Parkland Memorial Hospital. During the period 1970 - 1996 he resided at the University of Arizona, where he still holds the title of Professor Emeritus of Surgery/Urology and Founding Chief of Urology. Dr. Drach received his medical degree at Case Western Reserve University, Cleveland, Ohio, and then spent two years in surgical training at University Hospitals of Cleveland. His training was interrupted by two years of active duty in the US Navy, part of which time was spent as Chief Medical Officer of the aircraft carrier USS Valley Forge. Upon returning to civilian activity, he completed one year of fellowship in urology (endocrinology) and three years of urology residency under Dr. William Boyce at Wake Forest University in North Carolina. He completed his training in 1969, and then completed a medical fellowship at the University of New Mexico. He subsequently moved to his position at the University of Arizona.

He is the author of over 112 journal articles, 33 book chapters and 3 books or monographs. He functioned as editor of the American Urological Association (AUA) CME Interactive Education series on Patient Management Problems from 1996 to 2003 and was Chairman of the AUA Publications Committee from 1985 - 1987. He has served nationally as president of many organizations, including the Western Section AUA, the American Board of Urology, the Residency Review Committee for Urology, the Society of University Urologists, the Clinical Society of Genitourinary Surgeons, and the Society for Research on Calculous Kinetics (the ROCK Society). He received the AUA Hugh Hampton Young (outstanding contributions to American urology) and AUA Research Innovator (significant contributions to research) and Certificate of (Lifetime) Achievement awards in 1986, 1990, and 2004, respectively. He served as the Study Monitor for the United States Lithotripter Study (Dornier, Inc. and the National Electrical Manufacturers Assn.) 1982 - 1996, and received the honor of "Father of American Lithotripsy" in 1993. His major research interests include urinary stone disease, urinary and prostatic infections, mechanisms of urinary flow change with aging, and geriatric urology. As a result of this latter interest, he is now Chairman of the AUA Committee for Geriatric Urology, and Past-President of the Geriatric Urological Society. He also serves within the American Geriatric Society as Chairman of the Section on Surgery and Related Medical Specialties.

Karl-Erik Andersson
Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA

Karl-Erik Andersson, MD, PhD was born and raised in Sweden. He received his medical degree from the University of Lund in 1968, where he subsequently worked as a lecturer in clinical pharmacology. He completed his PhD at the Department of Pharmacology, Lund University, in 1973. In 1975 he obtained a Swedish specialist degree in Internal Medicine and was appointed Professor of Clinical Pharmacology at the University of Odense, Denmark. From 1976 to 1978 he also held the same position at the University of Aarhus, Denmark. From 1978-2006 he was Professor and Chairman of the Department of Clinical Pharmacology, University of Lund, Lund, Sweden. He has been visiting professor at the Department of Obstetrics and Gynecology, University of Toronto (1983-1985) and at the Department of Urology, University of Virginia, Charlottesville, USA (1997-1998). From 1993 to 2000 Dr. Andersson was Research Dean of the Medical Faculty at the University of Lund. Since 2006 he is Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Dr. Andersson is a member of many international societies including the American Urological Association, the European Association of Urology, and the International Society for Sexual Medicine. He also serves on the Editorial Boards of several journals, including Journal of Urology, Urology, European Urology, and Neurourology and Urodynamics.

Dr. Andersson is Editor-in-Chief of UroToday International Journal. During his career, he has authored more than 700 articles in peer-reviewed international journals. His research interests include urogenital and cardiovascular pharmacology and physiology, clinical trials, and regenerative pharmacology.

Mitchell C. Benson
George F. Cahill Professor and Chair Department of Urology, Columbia University College of P & S; Urologist in-Chief, New York Presbyterian Hospital - Columbia Campus

Mitchell Benson, MD began his affiliation with Columbia University College of Physicians and Surgeons in the Autumn of 1973 when he enrolled in Columbia College of Physicians and Surgeons as a first year medical student. He recognized early in his training that he wished to pursue a career in urology and following an internship and residency in general surgery at Mount Sinai Hospital in New York , he became a resident in urology at Presbyterian Hospital in New York in 1979. Following his chief residency in urology there, he went to Johns Hopkins Hospital and University where he was a Research Fellow in Urologic Oncology from 1982-1984.

After completion of his fellowship, Dr. Benson returned to Columbia University where he joined the urology faculty. Dr. Benson was one of the first recipients of the Herbert Irving Assistant Professor awards and he was the Herbert Irving Assistant Professor of Urology from July 1988 - June 1991. He was then promoted to Associate Professor of Urology, and in July 1995 to Professor of Urology. In 1997, he was named the George F. Cahill Professor of Urology. In November 2003, he was named the Director of the Comprehensive Cancer Center of Columbia University. In August 2005, he was appointed The George F. Cahill Professor and Chairman of the Department of Urology and Urologist-in-Chief at Columbia University Medical Center. During his career, Dr. Benson has been the recipient of numerous Honors. After having been elected to Phi Beta Kappa at Union College, he was awarded the Urology Prize from Columbia University College of Physicians and Surgeons. During his residency, he was awarded 1st Prize at the New York Academy of Medicine in the Ferdinand C. Valentine Resident's Essay Contest. He has won prizes for his clinical research from the American Urological Association in 1987 and 1991.

Dr. Benson's research has been and continues to be supported by the National Cancer Institute and he has participated in numerous projects sponsored by the pharmaceutical industry. He has submitted or published 195 scientific articles since 1984. He has presented more than 200 papers at National Meetings.

Ralph V. Clayman
Dean, UC-Irvine School of Medicine, University of California, Irvine, CA USA

Ralph V. Clayman, MD, is a graduate of Grinnell College and the University of California, San Diego School of Medicine. His general surgery and urology training were at the University of Minnesota, and from there, he went on to spend two years at Southwestern Medical School in Dallas pursuing his interests in renal cancer research, kidney stone disease, and minimally invasive urology. In 1984 he came to Washington University in St. Louis where he practiced for the ensuing 17 years - rising to the rank of Professor of Urology and Radiology as well as Director of the Midwest Stone Institute, and Co-Director of the Division of Minimally Invasive Surgery.

In January 2002, he accepted the Chair of the newly formed Department of Urology at the University of California-Irvine. For the past 20 years, Dr. Clayman has concentrated his energies on developing new applications of minimally invasive surgery to the treatment of kidney stone disease, kidney cancer, strictures of the ureter, and all aspects of kidney and ureteral surgery. He and his associates have been world leaders in this area, having performed the world's first laparoscopic removal of a kidney for both benign disease and for cancer, the first laparoscopic removal of a kidney and ureter to treat cancer, the development of a unique cutting balloon catheter to treat obstruction of the ureter, and some of the initial work on both percutaneous and endoscopic therapy for ureteral and kidney stones of all sizes. In addition, by establishing the first fellowship program in minimally invasive urology, Dr. Clayman has had the opportunity to develop the next generation of urologists in their commitment to less invasive surgery. Past trainees of his program now occupy academic positions in universities throughout the United States, Canada, and Israel.

Dr. Clayman has written textbooks on both laparoscopic and percutaneous urologic surgery and has published over 300 peer review papers and book chapters. He is co-founder and co-editor of the Journal of Endourology, which concentrates on less invasive urologic surgery. He is named on 7 patents having to do with minimally invasive surgical instrumentation. He has received numerous national and international awards, including the 2001 EXCEL award from the Society of Laparoscopic Surgeons. Dr. Clayman's patient care, teaching, and laboratory efforts are all focused on developing a kinder, gentler surgery in which incisions are either reduced in size or even eliminated. In order to accomplish this goal, he and his team continue to explore a broad range of minimally invasive and noninvasive surgery in order to bring modern day technology into the operating room and to the surgical bedside.

Roger R. Dmochowski
Professor, Department of Urology, Vanderbilt University, Nashville, TN USA

Roger R. Dmochowski, MD, in addition to his position of professor at the Department of Urology at Vanderbilt University in Nashville is also Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Dmochowski received his medical degree from the University of Texas Medical Branch at Galveston. He completed an internship and residency in surgery and urology at the University of Texas Medical School at Houston and at the M.D. Anderson Hospital and Tumor Institute in Texas. In addition, Dr. Dmochowski is subspecialty fellowship trained in female urology, neurourology, urodynamics and reconstructive urology and is board certified in urology.

Dr. Dmochowski has published more than 85 articles and book chapters, and 200 abstracts, and has given 100 presentations at various national and international meetings. He has been featured in audio/visual presentations on the management of urinary incontinence. Dr. Dmochowski is on the editorial board for the World Journal of Urology, Neurourology and Urodynamics, and International Journal of Urogynecology and the AUA Office of Education CD-ROM Series. Additionally, he is a reviewer for the Journal of Urology, and Urology. He is a Fellow of the American College of Surgeons and a member of the American Urological Association and International Continence Society. Dr. Dmochowski has been granted the Zimskind Award from the Urodynamics Society for his accomplishment in clinical treatment for incontinence.

His current research interests are outcomes of incontinence therapies with a particular emphasis on quality of life issues. He also is active in biomaterials evaluation.

Pamela I. Ellsworth
Associate Professor Surgery (Urology), Alpert Medical School of Brown University, Providence, RI  USA

Pamela Ellsworth, MD is an Associate Professor of Urology/Surgery and Pediatrics at the Warren Alpert Medical School at Brown University, Providence, Rhode Island, as well as a member of the urology staff at Rhode Island Hospital, Hasbro Children’s Hospital, Women and Infants Hospital, and Providence VA Medical Center. Dr. Ellsworth is a summa cum laude graduate of Boston College and received her MD from The University of Massachusetts Medical School. She completed her urology residency at Dartmouth-Hitchcock Medical Center and had a fellowship in Pediatric Urology at the University of Florida-Gainesville. She has been certified and recertified by the American Board of Urology. Dr. Ellsworth is a member of several organizations/medical societies including the American College of Surgeons, the American Urological Association, and the American Academy of Pediatrics. She serves as a reviewer for several medical journals.

Dr. Ellsworth has lectured throughout the world on a variety of urologic topics, and has served as a volunteer on surgical and educational missions to Guatemala and East Africa. She is the author of over 40 publications and a similar number of book chapters. She has authored five books including: 100 Questions & Answers about Erectile Dysfunction, 100 Questions & Answers about Prostate Cancer, 100 Questions & Answers About Bladder Cancer, and 100 Questions & Answers About Overactive Bladder and Urinary Incontinence.

In addition to her pediatric urology interests, her adult urology interests include overactive bladder, male sexual dysfunction, and prostate cancer.

Christopher P. Evans
Professor & Chairman Department of Urology, University of California-Davis, School of Medicine, Sacramento, CA USA

Christopher P. Evans, MD, FACS is Professor and Chairman, Department of Urology, University of California, Davis, School of Medicine. Dr. Evans is a graduate of the University of Vermont and received his MD degree from Dartmouth Medical School in Hanover, New Hampshire. Dr. Evans received a United States Army Health Services Professional Scholarship and served as the Chief of Experimental Surgery at the Walter Reed Army Institute of Research. He completed surgery and urology training at the University of California, San Francisco School of Medicine where he was also a National Kidney Foundation Research Scholar. He performed a fellowship in Urologic Surgical Oncology at the University of Texas, M.D. Anderson Cancer Center.

Dr. Evans joined the University of California, Davis School of Medicine in 1997 and is a member of the U.C. Davis Cancer Center and Co-Director of the U.C. Davis GU Oncology Clinical Trials Group. Dr. Evans served on the Board of Directors of the Society of Urologic Oncology, is past President of the Urologic Research Society and has sat on numerous committees in the American Association for Cancer Research. Dr. Evans is on the Editorial Board and is an Associate Editor of Prostate Cancer and Prostatic Diseases, British Journal of Urology International and the World Journal of Urology. He previously was the bladder cancer section editor for Current Opinion in Urology.

Dr. Evans is active in grant reviews for the American Cancer Society, the Department of Defense Prostate Program, the National Cancer Institute and the VA Merit Review Program. He is a Faculty Co-Chairman of the Annual Winter Urologic Forum. His professional affiliations include fellowship in the American College of Surgeons, the American Association for Advancement of Science, the American Association for Cancer Research, Southwest Oncology Group, Society of Urologic Oncology, the American Urological Association and its Western Section, Society for Basic Urologic Research, and the Association of Military Surgeons of the United States. He has received numerous awards including the Joseph F. McCarthy Essay Contest of the American Urological Association, the New York Academy of Medicine Edwin Beer Award and election into the American Association of Genitourinary Surgeons.

Dr. Evans maintains an active research laboratory focusing on prostate cancer, and specifically signal transduction regulation of the androgen receptor. He has received research funding from the National Institutes of Health, the Department of Defense, the American Cancer Society, the New York Academy of Medicine, The Prostate Cancer Foundation, the California Cancer Research Program, and the University of California Cancer Research Committee.

Philip M. Hanno
Professor of Urology Division of Urology, Department of Surgery, Hospital of the University of Pennsylvania; Medical Director, Department of Clinical Effectiveness and Quality Improvement, University of Pennsylvania Health System Philadelphia, PA USA

Philip M. Hanno, MD, MPH is a professor of urology in the Division of Urology at the Hospital of the University of Pennsylvania as well as Medical Director of the Department of Clinical Effectiveness and Quality Assurance of the University of Pennsylvania Health System. He has been Chief of the Division of Urology of the Philadelphia Veterans Administration Medical Center, Professor and Chair of the Department of Urology at Temple University School of Medicine, and a Medical Officer in the Division of Reproductive and Urologic Drugs in the Food and Drug Administration. He is currently on the FDA Urology Advisory Committee.

He has an interest in interstitial cystitis and female urology, and is Co-Chair of the Medical Advisory Board of the Interstitial Cystitis Association. He is Chair of the Audiovisual Committee of the American Urological Association and a member of the Program Committee and Education Council of the AUA as well.

William Jaffe
Assistant Professor, Department of Urology, Temple University School of Medicine Philadelphia, PA USA

William Jaffe, MD completed his undergraduate education, medical school, and residency at the University of Pennsylvania. In 2005 he completed a fellowship in Neurology, Voiding Dysfunction and Pelvic Reconstruction at New York- Presbyterian Hospitals. With a special interest in male and female incontinence, laser therapy for BPH, and neurologic diseases, he has joined the faculty at Temple University School of Medicine as Assistant Professor of Urology.

Dr. Jaffe has published numerous scientific papers and authored text book chapters on both female urology and BPH. He is a faculty member for the AUA course on BPH and regularly presents scientific data at national urology meetings.

S. Bruce Malkowicz
Co-Director, Urologic Oncology Program, Perelman Center for Advanced Medicine, Philadelphia, PA USA

S. Bruce Malkowicz, MD is a graduate of the University of Pennsylvania School of Medicine where he also received his general surgery and urology training. He was a clinical fellow in urological oncology at the University of Southern California and then completed an AFUD (American Foundation Urological Diseases) scholar program at the Wistar Institute.

He is the author of nearly 200 publications, and currently is a section editor for the British Journal of Urology International. He also serves on the editorial board of several other journals. He is the co-director of urologic oncology at the University of Pennsylvania and associate professor of surgery at Penn, and serves as chief of urology at the Philadelphia VA Medical Center.

His main areas of clinical interest are in the detection of bladder cancer, the molecular genetics/epidemiology of prostate cancer, clinical outcomes in prostate cancer therapy, and novel treatment for advanced bladder cancer.

Elspeth M. McDougall
Professor of Urology Director, Yamanouchi Center for Urological Education, University of California, Irvine, CA USA

Elspeth M. McDougall, MD, FRCSC joined the UCI faculty in 2002 to continue her clinical and research work in minimally invasive urologic surgery and assist in the development of a minimally invasive surgery education center. She is internationally recognized for her laboratory and clinical research in urologic laparoscopic surgery and for teaching courses on fundamental and advanced endourological and laparoscopic techniques. Dr. McDougall completed her medical training at the University of Calgary and the University of Ottawa in Canada, and then undertook a fellowship in endourology and extracorporeal shock wave lithotripsy (ESWL) with Dr.Ralph Clayman at Washington University School of Medicine. She joined the faculty at Washington University Medical School in 1991, where she spent nine years in academic urology.

While serving as Professor of Urologic Surgery at Vanderbilt University in Nashville, she developed the Endourology/Laparoscopic Urology Program there. She is a Fellow of the Royal College of Surgeons of Canada (Urology) and certified with the American Board of Urology. Dr. McDougall has published more than 132 peer-reviewed journal articles and numerous book chapters. She is the co-editor of two textbooks on laparoscopic surgery. She is chairperson for the Surgical Simulation Committee and a member of the Laparoscopic Training Committee of the American Urological Association. She is on the editorial boards of the Journal of Endourology and the Journal of the Society of Laparoendoscopic Surgeons. She is President of the Society of Laparoendoscopic Surgeons and a member of the World Congress of Endourology's Scientific Meeting Advisory Committee. She was recently elected to the prestigious American Association of Genitourinary Surgeons. Dr. McDougall is director of the Yamanouchi Center for Urological Education at UCI and developed the ongoing, five-day mini-residency training program in minimally invasive urologic surgery training academic and community urologists. She also is co-director of the annual New Frontiers in Endourology course at UCI.

Michael J. Metro
Associate Professor, Clinical Assistant Professor of Surgery, Urology Albert Einstein Medical Center, Philadelphia and Temple University Medical Center, Philadelphia, PA  USA

Michael J. Metro, MD , since 2001, has served as Clinical Assistant Professor of Urology at Albert Einstein Medical Center, Philadelphia, an affiliate of Thomas Jefferson Health System. He also serves in a similar capacity at Temple University Medical Center. Dr. Metro received his undergraduate degree in Biology and received his medical degree from the University of Pittsburgh in 1992 and 1996, respectively. He completed his surgical training and urologic residency at the Hospital of the University of Pennsylvania in 2001. He also went on, in 2002, to complete a fellowship in traumatic and reconstructive urology at the University of California, San Francisco under the direction of Dr. Jack W. McAninch and concurrently served as clinical instructor at San Francisco General Hospital.

He has authored several peer-reviewed journal articles and book chapters and is a co-editor of an upcoming book on urologic emergencies. He has presented at regional, national and international meetings on such topics as erectile dysfunction, urethral reconstruction and urologic trauma.

Harris M. Nagler
President, Beth Israel Medical Center, New York, NY USA

Harris M. Nagler, MD, FACS joined Beth Israel from Columbia Presbyterian Medical Center where he was on the faculty and did his residency in urology and a fellowship in reproductive medicine. He is a graduate of Union College and an AOA Medical Honor Society graduate of Temple University School of Medicine.

He is the recipient of many national and regional honors, having been recognized in New York Magazine as one of the "Best New York Doctors" in 1992, 1996, 1998, 1999, 2000 -2005 (each year that the list has been published). In 1994, he was honored by Resolve of New York's twentieth Year Celebration. In 1982 he was awarded the ACMI Urology Prize by the American Fertility Society. In the same year he received First Prize for Clinical Research in the American Urological Association Prize Essay Contest. In 1985, he was again recognized by the American Fertility Society (currently the American Society for Reproductive Medicine) when he was awarded the Urology Prize. In 1986, Columbia University honored him when he received the prestigious Drs. Harold and Goldman Lumpur Award for Excellence in Clinical Research. Dr. Nagler is a member or many prestigious organizations including the Alpha Omega Alpha medical Honor Society. In addition to membership in these societies he was the President of the Society for the Study of Male Reproduction of the American Urological Association and President of the Society of Reproductive Surgeons of the American Society of Reproductive Medicine. He is or has been the editorial boards of the Journal of Urology, Fertility and Sterility, Assisted Reproductive Reviews, Journal of Andrology, Molecular Andrology, Gynecologic and Obstetric Investigation and the Brazilian Journal of Urology.

He has published extensively in peer reviewed journals on many urological topics and has co-edited two books focusing on the treatment of male infertility. He has directed an annual instructional course on the Treatment of Male Infertility at the Annual Meeting of the American Urological Association. He has also directed or been a faculty member of AUA-sponsored microsurgical instructional courses. He is on the boards of many organizations including the Society for the Study of Male Reproduction and the New York Section of the American Urological Association.

Ricardo Sanchez-Ortiz
Assistant Professor of Urology, University of Puerto Rico School of Medicine and Adjunct Assistant Professor of Urologic Oncology, University of Texas/M. D. Anderson Cancer Center, Houston, TX USA

Ricardo Sanchez-Ortiz, MD graduated magna cum laude from Harvard University and earned his medical degree from the University of Puerto Rico. He completed his internship and urology residency at the University of Pennsylvania, where he also completed a basic science fellowship in voiding dysfunction under the direction of Drs. Alan J. Wein and Samuel Chacko. He then pursued a fellowship in urologic oncology at the M. D. Anderson Cancer Center, where he alsoconcurrently served as clinical specialist. Dr. Sanchez-Ortiz has authored over 30 original manuscripts and book chapters in urologic oncology and voiding dysfunction.

His research interests include renal cell carcinoma (surgical therapy in metastatic and locally advanced tumors, nephron sparing surgery), surgical management of prostate and penile cancer, continent reconstruction, and racial disparities in urological malignancies.

David P. Wood, Jr.
Professor and Chief of Urological Oncology, Department of Urology, University of Michigan Medical School, Ann Arbor, MI USA

David P. Wood, Jr., MD is a 1983 graduate of the University of Michigan Medical School and went on to fulfill his residency in urology at the Cleveland Clinic, followed by a clinical and research fellow at Memorial Sloan Kettering Cancer Center. During this fellowship program, he developed an active basic science laboratory, evaluating circulating prostate cancer cells.

Subsequently, Dr. Wood was appointed to the position of Assistant Professor and Chief of Urologic Oncology at the University of Kentucky. There he received NIH funding for his work in circulating prostate cancer cells and developed an active clinical trials-based urologic oncology program. In 1996, he moved to the newly formed Karmanos Cancer Institute at Wayne State University where he became Professor of Urology and Program Leader of the Prostate Cancer Program in the Cancer Center. He continued his research and began developing active clinical trials based research programs evaluating novel agents before radical prostatectomy or radical cystectomy. In 2002, he moved to the University of Michigan to assume the role of Chief of Urologic Oncology in the Department of Urology. There he actively oversees the Combined Minimally Invasive Fellowship Program that includes 1 ½ years of clinical and 1 ½ years of research activities.

Dr. Wood is active in the American Board of Urology and the American Urological Association, participating in many AUA courses and plenary sessions. He has also served on the Qualifying Exam Committee. He is on the editorial board of the Journal of Urology and is a peer review expert for many of the top urological journals. Dr. Wood continues his grant funding through the National Cancer Institute and is co-director of the annual Winter Urological Forum. He is head of the local bladder committee in the Southwest Oncology Group GU program. He remains active in numerous clinical trials to develop improvements in the quality of care in patients with urologic cancers.